Clinical Trial

Fixed-dose Combination of 1000 mg Dipyrone Monohydrate + 60 mg Caffeine + 4 mg Chlorpheniramine Maleate in Improving Symptoms of the Common Cold and Flu in Adults

Study acronym: PANAMA
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Phase III clinical trial to evaluate the efficacy and safety of a fixed-dose combination of 1000 mg dipyrone monohydrate + 60 mg caffeine + 4 mg chlorpheniramine maleate in improving symptoms of the common cold and flu in adults.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-02.
Trial Details
NCT Number NCT07626437
Lead Sponsor Brainfarma Industria Química e Farmacêutica S/A
Conditions Common Cold/Flu, Nasal Congestion, Nasal Obstruction
Enrollment 620 participants
Start Date 2026-05-08
Primary Completion 2027-06-28 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-16